Latest News

Genomic features of AML in patients over age 60 can predict success of stem cell transplant

For older patients with acute myeloid leukemia (AML), the prospects for success of a stem cell transplant can often be predicted based on the particular set of genetic mutations within the tumor cells, investigators at Dana-Farber Cancer Institute and other research centers will report today at the 61st American Society of Hematology (ASH) Annual Meeting.

Source link

Related posts

A newcomer rises to the defense of pharma — and tries to salvage its bruised reputation


Philips Shows Off Its Latest Health Tech at CES 2019


Critical components for implementing AI


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World